The Center for Global Development and Ariadne Labs have teamed up to better understand how long it will take to develop a COVID-19 vaccine and manufacture it at scale.
As companies race to find a vaccine for COVID-19, many have wondered how effective an eventual vaccine will be, how quickly it can be produced at scale, and how it can be distributed equitably around the globe.
Ariadne Labs' Vaccine Delivery efforts are focused on addressing these questions and identifying solutions to ensure that countries worldwide benefit from the advent of a vaccine.
Resources
Vaccine Preliminary Results: Here Is Why We Need to Exercise Caution
Anthony McDonnell, Robert Van Exan, Kalipso Chalkidou, Julie Rosenberg, Rebecca Weintraub, and Prashant Yadav Much of the discussion around society’s ability to return to “normality” after the COVID-19 pandemic has...
Perspectives
News
Radio Open Source: Warped Speed
Dr. Rebecca Weintraub joins Radio Open Source to discuss the race for a COVID-19 vaccine.
HuffPost: The Vaccine Race Has Become A High-Stakes Geopolitical Gamble
Dr. Rebecca Weintraub on the need for global COVID-19 vaccine initiative.
HuffPost France: Coronavirus Vaccine Race
Dr. Rebecca Weintraub speaks about the international scramble to produce a COVID-19 vaccine.
Times Radio: Vaccine Nationalism
Dr. Rebecca Weintraub joins Times Radio UK to discuss vaccine nationalism (at ~65 minute mark)
Marketplace: U.S. and EU vaccine deals raise fears of ‘vaccine nationalism’
Dr. Rebecca Weintraub joins Marketplace to discuss the risks of vaccine nationalism.
Dr. Rebecca Weintraub featured in Netflix series, Coronavirus Explained
The second part of a three-part Netflix series, “Coronavirus, Explained,” features Rebecca Weintraub, MD, the director of Ariadne Labs’ Better Evidence Program, speaking on the issue of...
Aspen Institute: The Biggest Challenge for a COVID-19 Vaccine
Dr. Rebecca Weintraub is quoted from her article on the issue of vaccine nationalism.
Maclean’s: How geopolitics is shaping the race for a coronavirus vaccine
Rebecca Weintraub speaks with Maclean's about the need to ensure equitable vaccine delivery.
